In this clinical entity of lean NASH, the restriction of fat contents and supplementation of choline is required and measurement of PEMT activity is beneficial to define the clinical entity of lean NASH. The gene discussed is PEMT; the disease is metabolic dysfunction-associated steatohepatitis.